Please assess the completion status of the following clinical trial:

Trial Title: Trial of Late Surfactant to Prevent BPD: A Pilot Study in Ventilated Preterm Neonates Receiving Inhaled Nitric Oxide

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Less than or equal to 1000 gm. birth weight~* Less than or equal to 30 weeks gestational age~* Day 7-14 of life~* Intubated and mechanically ventilated at any time days 7-14 of life~Exclusion Criteria:~* Serious congenital malformations~* Life expectancy less than 7 days from enrollment~* Previous treatment with iNO~* Active pulmonary hemorrhage at time of enrollment~* Active air leak syndrome at time of enrollment~* Bilateral grade IV intracranial hemorrhage prior to enrollment~* Less than 48 hours from last clinical dose of early surfactant.

- Gender: ALL
- Minimum Age: 7 Days
- Maximum Age: 14 Days
- Healthy Volunteers: f

Study Arms:
- Treatment Surfactant (Infasurf) ONY, NY (Type: ACTIVE_COMPARATOR): Patients receive inhaled nitric oxide and scheduled doses of Infasurf on study days 0, 3, 7, 10, and 14, if infant remains ventilated.
- Sham (no treatment) (Type: PLACEBO_COMPARATOR): Infants receiving inhaled nitric oxide will receive Sham (no treatment) on study days 0, 3, 7, 10, and 14, if infant remains ventilated.

Based on this trial design, predict the completion outcome and termination type (if applicable).